hepatitis%20-%20viral%20(pediatric)
HEPATITIS - VIRAL (PEDIATRIC)
The majority of acute viral hepatitis infections are asymptomatic or they can cause an anicteric illness that may not be diagnosed as hepatitis.
Hepatitis A generally causes minor illness in childhood with >80% of infections being asymptomatic. Jaundice and intestinal symptoms usually resolve 2-3 weeks after onset. A patient is infectious 1-2 weeks prior to the clinical illness.
Hepatitis B, C, & D may be symptomatic depending on the mode and time of transmission.
Hepatitis A is predominantly transmitted through oral-fecal by person-person direct transmission and contaminated material or food.
Hepatitis B is transmitted perinatal, horizontal spread, percutaneous, sexual, close person-to-person contact.
Majority of hepatitis C infections are identified in children with repeated exposure to blood products.
Hepatitis D is route of transmission is through sexual, percutaneous especially IV drug use.
Hepatitis E is transmitted primarily through contaminated drinking water and oral-fecal transmission.

Hepatitis - Viral (Pediatric) Drug Information

Drug Information

Indication: Avaxim 80U Active immunisation against infection caused by HAV in childn 12 mth-15 yr. Avaxim 160U Prevention ...

Indication: Agammaglobulinemia/hypogammaglobulinemia. Combined therapy w/ antibiotics in severe bacterial or viral infecti...

Indication: Immunization against infections caused by all known subtypes of HBV.

Indication: Prophylaxis of hepatitis B after exposure to HBsAg eg, by accidental "needle-stick" or direct mucous membrane ...

Indication: In combination w/ other antiretroviral agents for HIV-1 infections in adult & paed patients ≥12 yr. Chr...

Indication: In combination w/ other antiretroviral for treatment of HIV infected adult & childn.

Indication: HIV infection. 

Indication: HIV infection.

Indication: Active immunisation against HBV infection caused by all known subtypes in subjects considered at risk of expos...

Indication: Replacement therapy in primary immunodeficiency syndromes eg, congenital agammaglobulinaemia & hypogammagl...

1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).